{
  "id": "MISSION_BOWTIE_500_23_1771345225545",
  "questionType": "bowtie",
  "caseId": "CARDSHOCK_500",
  "stem": "The nurse is reviewing the electronic health record (EHR) for a client admitted with acute decompensated heart failure. The provider has just entered new orders. Based on the most recent client data, what action is most appropriate for the nurse to take? What condition is the client most likely experiencing? What three parameters should the nurse monitor to assess for improvement?",
  "tabs": [
    {
      "id": "Nurses' Notes",
      "content": "45-year-old male with a history of hypertension presented to the ED with severe shortness of breath and fatigue that has worsened over the last 3 days, following a recent 'flu-like' illness. The client reports living in a rural community with limited access to regular medical care. \n\n**0800 (08:00):** Admitted to the cardiac step-down unit. Alert and oriented x4, anxious. Reports dyspnea at rest. Lungs with crackles halfway up bilaterally. 2+ pitting edema in lower extremities. Skin is pale, cool, and diaphoretic. S1 and S2 heart sounds audible, with an S3 gallop noted. Abdomen soft, non-distended.\n\n**0930 (09:30):** Client has become increasingly restless and is confused to time and place. States, 'I can't breathe.' Fingertips and lips are dusky. Urine output via indwelling catheter is 15 mL in the past hour."
    },
    {
      "id": "Vital Signs",
      "content": [
        {
          "label": "Time",
          "values": [
            "0800",
            "0900",
            "0930"
          ]
        },
        {
          "label": "Heart Rate (/min)",
          "values": [
            "112",
            "128",
            "138"
          ]
        },
        {
          "label": "Blood Pressure (mmHg)",
          "values": [
            "104/68",
            "90/60",
            "82/58"
          ]
        },
        {
          "label": "Respiratory Rate (/min)",
          "values": [
            "24",
            "28",
            "32"
          ]
        },
        {
          "label": "SpO2 (%)",
          "values": [
            "92% on 4L NC",
            "90% on 6L NC",
            "89% on 15L NRB"
          ]
        },
        {
          "label": "Temperature (Â°C)",
          "values": [
            "37.1",
            "37.0",
            "36.9"
          ]
        }
      ]
    },
    {
      "id": "Laboratory Results",
      "content": [
        {
          "test": "Potassium",
          "value": "2.4 mEq/L",
          "reference": "3.5-5.0 mEq/L"
        },
        {
          "test": "Sodium",
          "value": "132 mEq/L",
          "reference": "136-145 mEq/L"
        },
        {
          "test": "BUN",
          "value": "48 mg/dL",
          "reference": "10-20 mg/dL"
        },
        {
          "test": "Creatinine",
          "value": "2.5 mg/dL",
          "reference": "0.6-1.2 mg/dL"
        },
        {
          "test": "Lactate, Venous",
          "value": "5.8 mmol/L",
          "reference": "0.5-2.2 mmol/L"
        },
        {
          "test": "Troponin I",
          "value": "3.1 ng/mL",
          "reference": "<0.04 ng/mL"
        },
        {
          "test": "BNP",
          "value": "2800 pg/mL",
          "reference": "<100 pg/mL"
        }
      ]
    },
    {
      "id": "Diagnostics",
      "content": "**12-Lead ECG Report (0830 (08:30)):** Sinus tachycardia with diffuse ST-segment elevation. Frequent premature ventricular contractions (PVCs) noted. \n\n**Echocardiogram Summary (from ED):** Severely reduced left ventricular ejection fraction estimated at 15-20%. Global hypokinesis. Findings suggestive of acute myocarditis."
    },
    {
      "id": "MAR",
      "content": [
        {
          "medication": "Furosemide 40 mg IV PUSH",
          "route": "IV",
          "frequency": "ONCE NOW (0930 (09:30))"
        },
        {
          "medication": "Potassium Chloride 20 mEq in 100 mL NS",
          "route": "IV",
          "frequency": "Infuse over 2 hours"
        },
        {
          "medication": "Norepinephrine Infusion",
          "route": "IV",
          "frequency": "Titrate to maintain MAP > 65 mmHg (Pending central line placement)"
        },
        {
          "medication": "Oxygen",
          "route": "Inhalation",
          "frequency": "Titrate to maintain SpO2 > 92%"
        }
      ]
    },
    {
      "id": "SBAR",
      "content": "**SITUATION (0935):** 45-year-old male admitted with acute decompensated heart failure, worsening shortness of breath, and fatigue.\n**BACKGROUND:** History of hypertension, recent 'flu-like' illness, lives in a rural area with limited access to care. Admitted at 0800 with crackles, edema, and S3 gallop. Echocardiogram shows severely reduced LVEF (15-20%) and possible myocarditis.\n**ASSESSMENT:** Client is increasingly restless and confused. Vital signs show hypotension (82/58), tachycardia (138), tachypnea (32), and hypoxemia (89% on 15L NRB). Urine output is low (15 mL/hr). Labs show hypokalemia (2.4 mEq/L), elevated BUN/Creatinine, elevated lactate, elevated troponin, and elevated BNP. ECG shows sinus tachycardia with ST elevation and PVCs.\n**RECOMMENDATION:** I am concerned about the client's worsening condition and the order for furosemide 40 mg IV push due to the client's hypotension, hypokalemia, and acute kidney injury. I recommend holding the furosemide, notifying the provider immediately, and initiating the potassium chloride infusion. The client may require vasopressor support and further evaluation for cardiogenic shock."
    }
  ],
  "prompt": "Based on the provided client data, what action is most appropriate for the nurse to take? What condition is the client most likely experiencing? What three parameters should the nurse monitor to assess for improvement?",
  "bowtie": {
    "action": [
      {
        "id": "A1",
        "text": "Administer the IV furosemide as ordered."
      },
      {
        "id": "A2",
        "text": "Withhold the IV furosemide and notify the provider."
      },
      {
        "id": "A3",
        "text": "Administer a 500 mL bolus of 0.9% sodium chloride."
      },
      {
        "id": "A4",
        "text": "Prepare the client for immediate endotracheal intubation."
      },
      {
        "id": "A5",
        "text": "Initiate the potassium chloride infusion immediately."
      }
    ],
    "condition": [
      {
        "id": "C1",
        "text": "Cardiogenic Shock"
      },
      {
        "id": "C2",
        "text": "Septic Shock"
      },
      {
        "id": "C3",
        "text": "Acute Respiratory Distress Syndrome (ARDS)"
      },
      {
        "id": "C4",
        "text": "Hypovolemic Shock"
      },
      {
        "id": "C5",
        "text": "Anaphylactic Shock"
      }
    ],
    "parameter": [
      {
        "id": "P1",
        "text": "Mean Arterial Pressure (MAP)"
      },
      {
        "id": "P2",
        "text": "Serum Potassium"
      },
      {
        "id": "P3",
        "text": "Urine Output"
      },
      {
        "id": "P4",
        "text": "Blood Glucose"
      },
      {
        "id": "P5",
        "text": "Temperature"
      },
      {
        "id": "P6",
        "text": "Abdominal Girth"
      },
      {
        "id": "P7",
        "text": "Pupillary Response"
      }
    ]
  },
  "answer": [
    "A2",
    "C1",
    [
      "P1",
      "P2",
      "P3"
    ]
  ],
  "answerBreakdown": {
    "action": {
      "A1": "Incorrect. (-)\nAdministering furosemide, a potent loop diuretic, is contraindicated and extremely dangerous in this client. \n\n*Pathophysiology Rationale:* The client's severely compromised state includes hypotension (82/58 mmHg), acute kidney injury (BUN 48 mg/dL, Creatinine 2.5 mg/dL), and critical hypokalemia (K+ 2.4 mEq/L). Furosemide inhibits sodium and chloride reabsorption in the loop of Henle, leading to increased excretion of water, potassium, and sodium. In this client, it would further reduce blood pressure by decreasing circulating volume, worsen renal perfusion due to decreased cardiac output and intravascular volume, and exacerbate hypokalemia, potentially leading to life-threatening cardiac arrhythmias, especially given the existing PVCs.\n\n*Clinical Pearl:* Never administer diuretics to hypotensive patients with acute kidney injury and hypokalemia without addressing these underlying issues first.",
      "A2": "Correct. (+)\nThis is the critical 'Safety Stop' action. The nurse must recognize the multiple contraindications to administering furosemide: severe hypotension, acute kidney injury, and life-threatening hypokalemia. \n\n*Pathophysiology Rationale:* Withholding the medication and immediately notifying the provider is crucial to prevent further harm. The client's compensatory mechanisms are failing, and administering furosemide would push them further into decompensation. The provider needs to be alerted to reassess the treatment plan and address the underlying causes of the client's condition.\n\n*Clinical Pearl:* Always prioritize patient safety by questioning orders that could potentially harm the patient, especially when multiple contraindications are present.",
      "A3": "Incorrect. (-)\nThe client is in cardiogenic shock, not hypovolemic shock. \n\n*Pathophysiology Rationale:* Cardiogenic shock results from the heart's inability to pump enough blood to meet the body's needs. The client already exhibits signs of fluid overload, including lung crackles, an S3 gallop, and an elevated BNP (2800 pg/mL). Administering a fluid bolus would increase preload on an already failing heart, worsening pulmonary edema and further compromising cardiac function. This can lead to increased pulmonary congestion and respiratory distress.\n\n*Clinical Pearl:* Assess for signs of fluid overload before administering fluids, especially in patients with known heart failure or suspected cardiogenic shock.",
      "A4": "Incorrect. (-)\nWhile the client is in respiratory distress and may eventually require intubation, this is not the most immediate independent nursing action.\n\n*Pathophysiology Rationale:* The client's respiratory distress is secondary to cardiogenic pulmonary edema. While respiratory support is important, the priority is to address the underlying cause of the shock and prevent further deterioration. Addressing the potentially harmful medication order takes precedence. Endotracheal intubation is a collaborative action that requires a provider's order and a respiratory therapist.\n\n*Clinical Pearl:* Prioritize interventions based on the ABCs (Airway, Breathing, Circulation), but always consider the underlying cause of the problem and address the most immediate threats to patient safety first.",
      "A5": "Correct Action, Incorrect Priority. (-)\nWhile the potassium infusion is essential and should be started, the absolute priority is to first prevent the administration of a medication (furosemide) that would make the hypokalemia and hypotension catastrophically worse.\n\n*Pathophysiology Rationale:* Hypokalemia can cause life-threatening cardiac arrhythmias, especially in the presence of myocardial ischemia (elevated troponin) and PVCs. While correcting the potassium level is crucial, preventing further potassium loss and hemodynamic instability from furosemide is the immediate priority. The principle of 'do no harm' dictates that preventing a medication error takes precedence over initiating corrective treatment.\n\n*Clinical Pearl:* In situations with multiple interventions, prioritize actions based on their potential to cause immediate harm. Preventing errors is always a top priority."
    },
    "condition": {
      "C1": "Correct. (+)\nThe client's presentation is classic for cardiogenic shock.\n\n*Pathophysiology Rationale:* Cardiogenic shock occurs when the heart is unable to pump enough blood to meet the body's metabolic demands, leading to inadequate tissue perfusion. This client exhibits evidence of severe cardiac dysfunction (EF 15-20%, elevated troponin/BNP), hypotension (BP 82/58 mmHg), tachycardia (HR 138 bpm), and signs of end-organ hypoperfusion (confusion, low urine output, elevated lactate, AKI). The elevated troponin suggests myocardial damage, while the elevated BNP indicates heart failure.\n\n*Clinical Pearl:* Cardiogenic shock is a life-threatening condition requiring immediate intervention to improve cardiac output and tissue perfusion.",
      "C2": "Incorrect. (-)\nThere are no signs of a systemic infection (e.g., fever, elevated WBC count) to suggest septic shock.\n\n*Pathophysiology Rationale:* Septic shock is caused by a systemic infection leading to vasodilation and decreased tissue perfusion. This client does not exhibit the typical signs of infection, such as fever or elevated white blood cell count. The primary cause of shock is cardiac pump failure, not infection.\n\n*Clinical Pearl:* Differentiate between different types of shock based on their underlying causes and clinical presentations.",
      "C3": "Incorrect. (-)\nWhile the client has hypoxemia and bilateral lung crackles, ARDS is a type of non-cardiogenic pulmonary edema.\n\n*Pathophysiology Rationale:* ARDS is characterized by acute, diffuse lung inflammation and increased permeability of the alveolar-capillary membrane, leading to pulmonary edema. This client's respiratory failure is a direct consequence of cardiogenic pulmonary edema from severe heart failure, not a primary lung injury.\n\n*Clinical Pearl:* ARDS is often triggered by sepsis, pneumonia, trauma, or aspiration. The absence of these triggers makes ARDS less likely in this scenario.",
      "C4": "Incorrect. (-)\nThe client's signs (crackles, edema, S3, high BNP) point to fluid overload, not fluid deficit.\n\n*Pathophysiology Rationale:* Hypovolemic shock results from a decrease in circulating blood volume, leading to decreased preload and cardiac output. This client exhibits signs of fluid overload, indicating that the cause of shock is pump failure, not low volume. The elevated BNP further supports the diagnosis of heart failure and fluid overload.\n\n*Clinical Pearl:* Assess for signs of fluid overload or deficit to differentiate between hypovolemic and cardiogenic shock.",
      "C5": "Incorrect. (-)\nThere is no history of allergen exposure or signs of an allergic reaction (e.g., urticaria, angioedema, wheezing) to suggest anaphylaxis.\n\n*Pathophysiology Rationale:* Anaphylactic shock is a severe allergic reaction causing vasodilation, bronchospasm, and increased capillary permeability. This client does not exhibit any signs of an allergic reaction, making anaphylaxis unlikely.\n\n*Clinical Pearl:* Anaphylactic shock typically presents with a rapid onset of symptoms following exposure to an allergen."
    },
    "parameter": {
      "P1": "Correct. (+)\nMean Arterial Pressure (MAP) is a critical parameter for assessing tissue perfusion and is the primary target for vasopressor therapy (e.g., norepinephrine) in cardiogenic shock.\n\n*Pathophysiology Rationale:* MAP reflects the average arterial pressure throughout the cardiac cycle and is a key indicator of tissue perfusion. In cardiogenic shock, maintaining a MAP >65 mmHg is crucial to ensure adequate blood flow to vital organs. Vasopressors increase MAP by constricting blood vessels and increasing cardiac output.\n\n*Clinical Pearl:* Titrate vasopressors to maintain a MAP within the target range, while closely monitoring for signs of end-organ ischemia.",
      "P2": "Correct. (+)\nThe client has life-threatening hypokalemia (2.4 mEq/L) and ventricular ectopy.\n\n*Pathophysiology Rationale:* Hypokalemia increases myocardial excitability and can lead to life-threatening arrhythmias, such as ventricular tachycardia and fibrillation. Correcting and closely monitoring the serum potassium level is a top priority to prevent fatal dysrhythmias and stabilize cardiac electrical activity. Potassium is essential for proper cardiac cell repolarization.\n\n*Clinical Pearl:* Monitor ECG for signs of hypokalemia (e.g., flattened T waves, U waves) and ventricular ectopy. Administer potassium cautiously and monitor serum levels frequently.",
      "P3": "Correct. (+)\nUrine output is a key indicator of renal and systemic perfusion.\n\n*Pathophysiology Rationale:* Adequate urine output reflects adequate renal perfusion and overall cardiac output. An increase in urine output would signify improved cardiac output and response to therapy, while continued oliguria would indicate worsening shock and inadequate renal perfusion. The kidneys are highly sensitive to changes in blood flow.\n\n*Clinical Pearl:* Monitor urine output hourly and report any significant decrease to the provider.",
      "P4": "Incorrect. (-)\nWhile stress hyperglycemia can occur in critical illness, monitoring blood glucose is not a primary parameter for assessing this client's specific hemodynamic instability and electrolyte crisis.\n\n*Pathophysiology Rationale:* While hyperglycemia can occur due to stress hormones released during shock, it is not the primary driver of the client's immediate instability. Addressing hypotension, hypokalemia, and improving cardiac output are the priorities.\n\n*Clinical Pearl:* Monitor blood glucose as part of routine care, but prioritize interventions based on the most immediate threats to patient safety.",
      "P5": "Incorrect. (-)\nThe client is afebrile and slightly hypothermic, consistent with poor perfusion.\n\n*Pathophysiology Rationale:* Hypothermia can occur in shock due to decreased metabolic rate and poor peripheral perfusion. While temperature is part of routine monitoring, it is not a priority parameter for evaluating the immediate response to interventions for cardiogenic shock. Addressing the underlying hemodynamic instability is more critical.\n\n*Clinical Pearl:* Monitor temperature as part of routine care, but prioritize interventions based on the most immediate threats to patient safety.",
      "P6": "Incorrect. (-)\nAbdominal girth is monitored for conditions like ascites or bowel obstruction, which are not relevant to the immediate management of this client's cardiogenic shock.\n\n*Pathophysiology Rationale:* Abdominal girth is not directly related to the pathophysiology of cardiogenic shock or the immediate interventions required. It is more relevant in conditions affecting the abdominal cavity.\n\n*Clinical Pearl:* Focus on parameters that directly reflect cardiac output, tissue perfusion, and electrolyte balance in cardiogenic shock.",
      "P7": "Incorrect. (-)\nWhile a change in pupillary response can indicate severe cerebral hypoperfusion or herniation, monitoring for subtle changes is less of a priority than monitoring direct indicators of cardiac output and perfusion like MAP and urine output.\n\n*Pathophysiology Rationale:* While neurological assessment is important, monitoring pupillary response is less sensitive than direct indicators of cerebral perfusion, such as level of consciousness and MAP. The client's confusion is already a sign of cerebral hypoperfusion, and improving MAP is the priority.\n\n*Clinical Pearl:* Prioritize interventions based on the most immediate threats to patient safety and the parameters that directly reflect the underlying pathophysiology."
    }
  },
  "clinicalPearls": [
    "In cardiogenic shock, avoid administering diuretics like furosemide if the client is hypotensive, hypokalemic, or has an acute kidney injury. Diuretics can worsen these conditions and lead to life-threatening complications.",
    "Prioritize addressing potentially harmful medication orders before initiating other treatments. The principle of 'do no harm' is paramount in nursing practice.",
    "Mean Arterial Pressure (MAP), serum potassium, and urine output are critical parameters to monitor in cardiogenic shock to assess tissue perfusion, electrolyte balance, and renal function."
  ],
  "sentinelStatus": "healed_v2026_v8"
}